Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

7PJR

Notum_ARUK3000438

Summary for 7PJR
Entry DOI10.2210/pdb7pjr/pdb
DescriptorPalmitoleoyl-protein carboxylesterase NOTUM, 2-acetamido-2-deoxy-beta-D-glucopyranose, DIMETHYL SULFOXIDE, ... (6 entities in total)
Functional Keywordsnotum inhibitor, signaling protein
Biological sourceHomo sapiens (Human)
Total number of polymer chains1
Total formula weight44576.48
Authors
Vecchia, L.,Zhao, Y.,Fish, P.,Jones, E.Y. (deposition date: 2021-08-24, release date: 2022-09-07, Last modification date: 2024-11-13)
Primary citationWillis, N.J.,Mahy, W.,Sipthorp, J.,Zhao, Y.,Woodward, H.L.,Atkinson, B.N.,Bayle, E.D.,Svensson, F.,Frew, S.,Jeganathan, F.,Monaghan, A.,Benvegnu, S.,Jolly, S.,Vecchia, L.,Ruza, R.R.,Kjaer, S.,Howell, S.,Snijders, A.P.,Bictash, M.,Salinas, P.C.,Vincent, J.P.,Jones, E.Y.,Whiting, P.,Fish, P.V.
Design of a Potent, Selective, and Brain-Penetrant Inhibitor of Wnt-Deactivating Enzyme Notum by Optimization of a Crystallographic Fragment Hit.
J.Med.Chem., 65:7212-7230, 2022
Cited by
PubMed Abstract: Notum is a carboxylesterase that suppresses Wnt signaling through deacylation of an essential palmitoleate group on Wnt proteins. There is a growing understanding of the role Notum plays in human diseases such as colorectal cancer and Alzheimer's disease, supporting the need to discover improved inhibitors, especially for use in models of neurodegeneration. Here, we have described the discovery and profile of (ARUK3001185) as a potent, selective, and brain-penetrant inhibitor of Notum activity suitable for oral dosing in rodent models of disease. Crystallographic fragment screening of the Diamond-SGC Poised Library for binding to Notum, supported by a biochemical enzyme assay to rank inhibition activity, identified and as a pair of outstanding hits. Fragment development of delivered that restored Wnt signaling in the presence of Notum in a cell-based reporter assay. Assessment in pharmacology screens showed to be selective against serine hydrolases, kinases, and drug targets.
PubMed: 35536179
DOI: 10.1021/acs.jmedchem.2c00162
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.51 Å)
Structure validation

229380

數據於2024-12-25公開中

PDB statisticsPDBj update infoContact PDBjnumon